Lixudebart is a humanised monoclonal antibody targeting CLDN1 (Claudin-1), which can be used to reverse organ fibrosis (such as pulmonary fibrosis) and reduce initial ALT/AST levels.
Purity:
99.00%
CAS Number:
[2749515-10-2]
Target:
Tight Junction Protein
* VAT and and shipping costs not included. Errors and price changes excepted
